Financials
- Market Capitalization 2.14 B
- Employee 128
- Founded 2012
- CEO N/A
- Website www.auriniapharma.com
- Headquarter Alberta, Canada
- FIGI BBG000BCRJM5
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
7.41
ratio cours/chiffre d'affaires
7.43
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 1927 | SRPT Sarepta Therapeutics, Inc. - Common Stock | 20.82 USD | -0.19% | +14.08% | +39.08% | +15.35% | 2.20 B USD | ||
| 1946 | MESO Mesoblast Limited - American Depositary Shares | 16.72 USD | -4.13% | +0.42% | +18.41% | +28.12% | 2.17 B USD | ||
| 1959 | ADMA ADMA Biologics Inc - Common Stock | 9.46 USD | +1.28% | -1.66% | +10.13% | -44.65% | 2.12 B USD | ||
| 1981 | URGN UroGen Pharma Ltd. - Ordinary Shares | 42.32 USD | -2.98% | -9.38% | +12.22% | +122.74% | 2.07 B USD |